bg
A

Agios (AGIO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Agios (AGIO)

Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more

  • USD40.68
  • USD41.67
  • USD40.18
  • USD53.29
  • -6.40%
  • 31M
  • 113.63k
  • 628.70k
  • 2.4B
  • 19.80
  • 68.80%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.